Chimeric Antigen Receptor T-Cell Therapy Is Associated with Low Absolute Rates of Orofacial Adverse Events and Significantly Less When Compared to Hemopoietic Stem Cell Therapy - Stella O. Oyewole; Emma Butler; Sagun D. Goyal; Adepitan A. Owosho (Dentistry Journal, 2026)